Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Principles of Drug Action01:24

Principles of Drug Action

6.7K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
6.7K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

2.1K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.1K
Cholinergic Antagonists: Therapeutic Uses01:26

Cholinergic Antagonists: Therapeutic Uses

904
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:    
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
904
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

4.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
4.9K
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

862
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
862
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

938
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
938

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Role of <i>REL</i> and <i>IL2</i> and Their Polymorphisms in the Pathogenesis of Vitiligo-Exploratory Genetic Association Study.

International journal of molecular sciences·2026
Same author

Resminostat for maintenance treatment in patients with advanced-stage mycosis fungoides or Sézary syndrome: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial.

The Lancet. Haematology·2026
Same author

The Role of Accessible Hematological Markers in Bullous Pemphigoid: A Systematic Review.

International journal of molecular sciences·2026
Same author

The Art of Interpreting Antinuclear Antibodies (ANAs) in Everyday Practice.

Journal of clinical medicine·2025
Same author

Senear-Usher Syndrome or Coexistence of SLE with Pemphigus Vulgaris-A Case Report with Literature Review.

Journal of clinical medicine·2025
Same author

Hidradenitis suppurativa: a new therapeutic approach for an old disease.

Postepy dermatologii i alergologii·2024

Related Experiment Video

Updated: Sep 21, 2025

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds
07:14

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds

Published on: July 11, 2025

186

Antimalarials - old drugs are new again.

Anna Woźniacka1

  • 1Department of Dermatology and Venereology, Medical University of Lodz, Lodz, Poland.

Postepy Dermatologii I Alergologii
|June 1, 2022
PubMed
Summary
This summary is machine-generated.

Hydroxychloroquine (HCQ) is a vital antimalarial drug for lupus erythematosus, offering disease modification and improved survival. Recent research supports revised dosing and expanded use, even in lupus nephritis and pregnancy, to maximize benefits and minimize side effects.

Keywords:
antimalarialschloroquinehydroxychloroquinelupus erythematosus

More Related Videos

Optimized Griess Reaction for UV-Vis and Naked-eye Determination of Anti-malarial Primaquine
08:31

Optimized Griess Reaction for UV-Vis and Naked-eye Determination of Anti-malarial Primaquine

Published on: October 11, 2019

10.4K
Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors
05:28

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors

Published on: May 12, 2022

3.1K

Related Experiment Videos

Last Updated: Sep 21, 2025

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds
07:14

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds

Published on: July 11, 2025

186
Optimized Griess Reaction for UV-Vis and Naked-eye Determination of Anti-malarial Primaquine
08:31

Optimized Griess Reaction for UV-Vis and Naked-eye Determination of Anti-malarial Primaquine

Published on: October 11, 2019

10.4K
Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors
05:28

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors

Published on: May 12, 2022

3.1K

Area of Science:

  • Rheumatology
  • Pharmacology
  • Immunology

Background:

  • Lupus erythematosus is a chronic autoimmune disease requiring long-term management.
  • Antimalarials, particularly hydroxychloroquine (HCQ), are foundational therapies for lupus.
  • Evolving research necessitates updates on HCQ's therapeutic role and safety profile.

Purpose of the Study:

  • To elucidate the therapeutic mechanism of action of antimalarials, specifically HCQ, in lupus erythematosus.
  • To review recent evidence for revising HCQ indications, dosage, and duration.
  • To highlight strategies for limiting adverse effects and optimizing patient outcomes.

Main Methods:

  • Review of recent scientific literature and clinical studies on hydroxychloroquine in lupus.
  • Analysis of historical and current therapeutic guidelines and dosage recommendations.
  • Examination of HCQ's impact on disease activity, organ damage, and survival.

Main Results:

  • Hydroxychloroquine is now recommended for all lupus patients, including those with lupus nephritis and pregnant women.
  • Current evidence supports a revised maximum dosage of 5.0 mg/kg real body weight.
  • HCQ demonstrates a favorable therapeutic profile, improving disease activity, survival, and preventing organ damage.

Conclusions:

  • Antimalarials are essential disease-modifying antirheumatic drugs requiring chronic administration.
  • Revised HCQ dosing and expanded indications enhance its therapeutic efficacy and safety in lupus management.
  • Adherence to prescriptions and novel formulations may improve long-term treatment outcomes.